Insights

Growing 2026 outlook Lonza reiterates a strong Full-Year 2026 outlook with 11-12% constant-currency sales growth and a CORE EBITDA margin of 33-34%, suggesting ample expansion opportunities in pharma, biotech, and specialty ingredients that sales teams can target with updated value propositions.

ADC collaboration Exclusive access agreements with Qurient for CDK7 inhibitors in dual-payload ADC programs indicate a strategic push into advanced biologics and targeted therapies, presenting cross-sell potential for Lonza's ADC development capabilities and regulatory/compliance services.

AI enabled discovery Partnership with Onava to enable AI-driven biologics discovery using Lonza GS Gene Expression System signals demand for optimized discovery platforms; opportunities exist to offer contract development, data analytics, and process validation services.

In vivo vector manufacturing Strategic collaboration with Asimov to advance lentiviral vector manufacturing for in vivo applications highlights demand for scalable GMP production, process development, and analytics, creating avenues for Lonza to provide end-to-end manufacturing support and compliance.

Capsugel nitrite testing New integrated capsule nitrite testing service positions Lonza Capsugel as a regulatory-compliant partner for oral dosage manufacturing, enabling cross-sell into existing pharma manufacturing customers seeking validated analytical methods and regulatory support.

Similar companies to Lonza Group

Lonza Group Tech Stack

Lonza Group uses 8 technology products and services including Canva, Microsoft SharePoint, OneTrust, and more. Explore Lonza Group's tech stack below.

Media & News

Lonza Group's Email Address Formats

Lonza Group uses at least 4 email formats:
Lonza Group Email FormatsExamplePercentage
First.Last@lonza.comJohn.Doe@lonza.com
95%
Last.First@lonza.comDoe.John@lonza.com
2%
First.Middle@lonza.comJohn.Michael@lonza.com
2%
FL@lonza.comJD@lonza.com
1%

Frequently Asked Questions

What is Lonza Group's phone number?

Minus sign iconPlus sign icon
You can contact Lonza Group's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Lonza Group's stock symbol?

Minus sign iconPlus sign icon
Lonza Group is a publicly traded company; the company's stock symbol is LZAG.

What is Lonza Group's official website and social media links?

Minus sign iconPlus sign icon
Lonza Group's official website is lonza.com and has social profiles on LinkedIn.

How much revenue does Lonza Group generate?

Minus sign iconPlus sign icon
As of July 2026, Lonza Group's annual revenue is estimated to be $25M - $50M.

What is Lonza Group's NAICS code?

Minus sign iconPlus sign icon
Lonza Group's NAICS code is 325 - Chemical Manufacturing.

How many employees does Lonza Group have currently?

Minus sign iconPlus sign icon
As of July 2026, Lonza Group has approximately 1 employees across 5 continents, including North America, Europe and Africa. Key team members include Global Head Of Sterility Assurance, Cell And Gene Technologies: D. C., Senior Vice President Human Resources: M. M. and Global Marketing Director: P. A. Explore Lonza Group's employee directory with LeadIQ.

What industry does Lonza Group belong to?

Minus sign iconPlus sign icon
Lonza Group operates in the Chemicals industry.

What technology does Lonza Group use?

Minus sign iconPlus sign icon
Lonza Group's tech stack includes Canva, Microsoft SharePoint, OneTrust, Microsoft 365, DocuSign, Cisco, LinkedIn Sales Navigator and SAP Concur.

What is Lonza Group's email format?

Minus sign iconPlus sign icon
Lonza Group's email format typically follows the pattern of First.Last@lonza.com. Find more Lonza Group email formats with LeadIQ.
Lonza Group logo

Lonza Group

ChemicalsTexas, United States0-1 Employees

Lonza Group operates in chemical manufacturing, serving the pharmaceutical, biotech, and specialty ingredient markets with products that support health-related outcomes. Based in Pasadena, Texas, the company targets customers involved in drug development and manufacturing processes. It maintains a small workforce.
In June 2026, Lonza announced an exclusive licensing agreement with Antharis Therapeutics to develop dual-payload antibody-drug conjugates for gastrointestinal cancers. The development highlights Lonza’s involvement in collaborative programs within the biopharma space.

Section iconCompany Overview

Phone number
Website
lonza.com
Stock Symbol
LZAG
NAICS Code
325 - Chemical Manufacturing
Employees
0-1

Section iconFunding & Financials

  • $25M - $50M

    Lonza Group's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.